Literature DB >> 11201098

Role of corticostriatal and nigrostriatal inputs in malonate-induced striatal toxicity.

A Meldrum1, S B Dunnett, B J Everitt.   

Abstract

The striatal neuronal loss evident following cellular metabolic compromise may be dependent upon the presence of glutamate and dopamine within the striatum. In order to investigate the relative roles of corticostriatal and nigrostriatal projections in malonate-induced neuronal loss, the extent of toxicity was quantified in animals with cortical lesions to deplete the striatum of glutamate, nigrostriatal lesions to deplete the striatum of dopamine, or both. We found that malonate-induced striatal toxicity was significantly reduced following lesions of either the glutamatergic or dopaminergic afferents to the striatum. The extent of attenuation following the loss of both inputs within the same animal was similar to that seen following lesions of either alone. These data suggest that malonate-induced toxicity in the striatum depends upon the integrity of interactive influences from both glutamatergic and dopaminergic afferents.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11201098     DOI: 10.1097/00001756-200101220-00025

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  4 in total

1.  Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?

Authors:  H-Q Wu; A Rassoulpour; R Schwarcz
Journal:  J Neural Transm (Vienna)       Date:  2006-08-24       Impact factor: 3.575

2.  Striatal damage and oxidative stress induced by the mitochondrial toxin malonate are reduced in clorgyline-treated rats and MAO-A deficient mice.

Authors:  William F Maragos; Kristie L Young; Chris S Altman; Chava B Pocernich; Jennifer Drake; D Allan Butterfield; Isabelle Seif; Daniel P Holschneider; Kevin Chen; Jean C Shih
Journal:  Neurochem Res       Date:  2004-04       Impact factor: 3.996

Review 3.  Mouse models of Huntington's disease and methodological considerations for therapeutic trials.

Authors:  Robert J Ferrante
Journal:  Biochim Biophys Acta       Date:  2009-04-10

4.  Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N-methyl-D-aspartate neurotoxicity.

Authors:  B Poeggeler; A Rassoulpour; H-Q Wu; P Guidetti; R C Roberts; R Schwarcz
Journal:  Neuroscience       Date:  2007-07-16       Impact factor: 3.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.